HIV treatment linked to risk of early knee osteoarthritis
View as a Web Page
News Medical
 
  HIV/AIDS HIV/AIDS logo  
  The latest HIV/AIDS news from News Medical  
 New WHO guidelines recommend injectable lenacapavir for HIV preventionNew WHO guidelines recommend injectable lenacapavir for HIV prevention
 
The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention, in a landmark policy action that could help reshape the global HIV response.
 
 
 HIV treatment linked to risk of early knee osteoarthritisHIV treatment linked to risk of early knee osteoarthritis
 
Acquired immune deficiency syndrome, or AIDS, caused by the human immunodeficiency virus (HIV), weakens the body's immune system and can be life-threatening if left untreated.
 
   Twice-yearly injection could transform HIV prevention efforts
 
Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A once-daily pill named PrEP, or pre-exposure prophylaxis, has been a stalwart for HIV prevention-but only if people take it consistently and can routinely access a pharmacy.
 
   Research highlights an increase in informal use of doxyPEP/PrEP among key populations in the NetherlandsResearch highlights an increase in informal use of doxyPEP/PrEP among key populations in the Netherlands
 
New research analyzing an online survey of 1,633 respondents found 15% recent use of doxycycline post- and pre-exposure prophylaxis (doxyPEP/PrEP) among men who have sex with men (MSM), transgender and gender diverse people in the Netherlands according to a recent study published by Eurosurveillance.
 
 USAID funding cuts could cost millions of lives worldwide, study warns
 
USAID funding cuts could cost millions of lives worldwide, study warnsA new study published in The Lancet has raised urgent concerns about the global health consequences of recent cuts to U.S. foreign aid.
 
 
 WHO maintains global emergency status for mpox following June 2025 IHR Emergency Committee meeting
 
WHO maintains global emergency status for mpox following June 2025 IHR Emergency Committee meetingThe Director-General of the World Health Organization (WHO) is hereby transmitting the report of the fourth meeting of the International Health Regulations (2005) (IHR) Emergency Committee (Committee) regarding the upsurge of mpox 2024, held on Thursday, 5 June 2025, from 12:00 to 17:00 CEST.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025